[Effect of beclin1 on vincristine-induced dopaminergic neurons injury in zebrafish]

Area of Science:

• Neuroscience
• Toxicology
• Molecular Biology

Background:

• Vincristine is a chemotherapy drug with known neurotoxic side effects.
• Dopaminergic neurons are crucial for motor control and are vulnerable to toxins.
• The precise mechanisms underlying vincristine neurotoxicity require further elucidation.

Purpose of the Study:

• To investigate the toxicity and mechanism of vincristine on dopaminergic neurons.
• To identify molecular targets for reducing vincristine-induced neurotoxicity.
• To utilize zebrafish as a model organism for this investigation.

Main Methods:

• Reverse transcription polymerase chain reaction (RT-PCR) to assess gene transcription.
• Western blotting to evaluate protein expression levels.
• Whole mount in situ immunofluorescence to visualize dopaminergic neurons.

Main Results:

• Vincristine inhibited tyrosine hydroxylase gene transcription and dopamine transporter protein expression.
• A dose-dependent decrease in dopaminergic neuron number was observed.
• Vincristine suppressed autophagy and inhibited beclin1 gene expression.

Conclusions:

• Beclin1 plays a significant role in vincristine-induced dopaminergic neuron toxicity.
• Upregulating beclin1 expression partially reduced neurotoxicity.
• Downregulating beclin1 exacerbated vincristine-induced toxicity, highlighting beclin1 as a potential therapeutic target.